The buyback is routine and small in scale relative to the company's market cap. Monitor future filings for any changes to the repurchase program or material pipeline updates for gamgertamig.
Price Chart
Executive Summary
Lakefront Biotherapeutics disclosed the repurchase of 126,322 of its own ordinary shares between October 5 and October 9, 2026, at an average price of €26.26 per share, for a total consideration of approximately €3.3 million. The buyback was executed under a repurchase program announced on June 9, 2026, and as of October 9, 2026, the company holds 1,877,353 of its own shares. This is a routine capital allocation disclosure with no material financial impact.
Key Facts
- Repurchased 126,322 shares between October 5 and October 9, 2026.
- Average price paid was €26.26 per share; total consideration was €3,317,407.94.
- Repurchase program was announced on June 9, 2026.
- As of October 9, 2026, Lakefront holds 1,877,353 of its own ordinary shares.
Financial Impact
Total repurchase of approximately €3.3 million, representing a small fraction of market cap.
Risk Factors
- No material risk identified from this routine buyback disclosure.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006602 |
| Document: f6k_101326.htm | 0001171843-26-006602 |
| Document: 0001171843-26-006602-index-headers.html | 0001171843-26-006602 |
| Document: 0001171843-26-006602-index.html | 0001171843-26-006602 |
| Document: 0001171843-26-006602.txt | 0001171843-26-006602 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 6-K | $30.58 | awaiting T+20 | — | $31.82 (+4.05%) |
Oct 14, 2026 12d ago | 6-K | $29.93 | awaiting T+20 | — | $31.82 (+6.31%) |
Oct 13, 2026 14d ago | 6-K | $29.40 | awaiting T+20 | — | $31.82 (+8.23%) |
Oct 6, 2026 21d ago | 6-K | $30.00 | awaiting T+20 | — | $31.82 (+6.07%) |
Sep 1, 2026 8w ago | 6-K | $28.81 $29.65 | ▲ +2.92% | ▲ +3.25% | $31.82 (+10.45%) |
Aug 25, 2026 9w ago | 6-K | $29.70 $30.72 | ▲ +3.43% | ▲ +2.46% | $31.82 (+7.14%) |
Aug 12, 2026 10w ago | 6-K | $27.93 $26.81 | ▼ −4.01% | ▼ −2.11% | $31.82 (+13.93%) |
Jul 28, 2026 13w ago | 6-K | $27.72 $29.16 | ▲ +5.19% | ▲ +0.17% | $31.82 (+14.79%) |
Jun 30, 2026 17w ago | 6-K | $29.60 $27.72 | ▼ −6.35% | ▼ −4.17% | $31.82 (+7.50%) |
Jun 24, 2026 17w ago | 6-K | $29.01 $28.78 | ▼ −0.79% | ▼ −2.73% | $31.82 (+9.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers